BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34078402)

  • 1. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.
    Bai R; Rebelo A; Kleeff J; Sunami Y
    Lipids Health Dis; 2021 Jun; 20(1):58. PubMed ID: 34078402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of Lipid Droplet-associated Genes as Diagnostic and Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
    Bai YT; Wang X; He MJ; Xie JR; Chen XJ; Zhou G
    Comb Chem High Throughput Screen; 2024; 27(1):136-147. PubMed ID: 36998140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
    Xu JS; Liao KL; Wang X; He J; Wang XZ
    J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipid droplet homeostasis by hypoxia inducible lipid droplet associated HILPDA.
    de la Rosa Rodriguez MA; Kersten S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158738. PubMed ID: 32417386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
    Subramanian C; Cohen MS
    Surgery; 2022 Jan; 171(1):119-129. PubMed ID: 34353633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
    Jia Y; Shen M; Zhou Y; Liu H
    Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid droplet storage promotes murine pancreatic tumor growth.
    Grachan JJ; Kery M; Giaccia AJ; Denko NC; Papandreou I
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HILPDA Regulates Lipid Metabolism, Lipid Droplet Abundance, and Response to Microenvironmental Stress in Solid Tumors.
    VandeKopple MJ; Wu J; Auer EN; Giaccia AJ; Denko NC; Papandreou I
    Mol Cancer Res; 2019 Oct; 17(10):2089-2101. PubMed ID: 31308147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
    Li C; Zeng X; Yu H; Gu Y; Zhang W
    World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics.
    Pi R; Chen Y; Du Y; Dong S
    Biomed Res Int; 2021; 2021():2602322. PubMed ID: 34957301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
    Zheng X; Liu X; Zheng H; Wang H; Hong D
    Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
    Zhou L; Song Z; Hu J; Liu L; Hou Y; Zhang X; Yang X; Chen K
    Theranostics; 2021; 11(2):841-860. PubMed ID: 33391508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
    Mitra R; Le TT; Gorjala P; Goodman OB
    BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
    Ma C; Cui Z; Wang Y; Zhang L; Wen J; Guo H; Li N; Zhang W
    Bosn J Basic Med Sci; 2021 Feb; 21(1):47-60. PubMed ID: 33188589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.
    Liang C; Shi S; Meng Q; Liang D; Hua J; Qin Y; Zhang B; Xu J; Ni Q; Yu X
    Int J Cancer; 2018 Dec; 143(11):2919-2931. PubMed ID: 29978477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
    Ye Y; Chen Z; Shen Y; Qin Y; Wang H
    FEBS Open Bio; 2021 Nov; 11(11):3153-3170. PubMed ID: 33386701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
    Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
    Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.